# EDGAR Filing Document

**Accession Number:** 0001333493
**File Stem:** 0001333493-25-000095
**Filing Date:** 2025-8
**Character Count:** 20762
**Document Hash:** 1652e01052d1dc9c067a2586471dda5f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001333493-25-000095.hdr.sgml**: 20250807

**ACCESSION NUMBER**: 0001333493-25-000095

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 15

**FILED AS OF DATE**: 20250807

**DATE AS OF CHANGE**: 20250807

**EFFECTIVENESS DATE**: 20250807

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** eHealth, Inc.
- **CENTRAL INDEX KEY:** 0001333493
- **STANDARD INDUSTRIAL CLASSIFICATION:** INSURANCE AGENTS BROKERS & SERVICES [6411]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 770470789
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-289366
- **FILM NUMBER:** 251194559

**BUSINESS ADDRESS:**
- **STREET 1:** 13620 RANCH ROAD 620 N, SUITE A250
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78717
- **BUSINESS PHONE:** 737-248-2340

**MAIL ADDRESS:**
- **STREET 1:** 13620 RANCH ROAD 620 N, SUITE A250
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78717

**As filed with the Securities and Exchange Commission on August 7, 2025**

**Registration No. 333-** 

---

| | | |
|:---|:---|:---|
| <br>**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION** | <br>**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION** | <br>**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION** |
| **Washington, D.C. 20549** | **Washington, D.C. 20549** | **Washington, D.C. 20549** |
| **FORM S-8** | **FORM S-8** | **FORM S-8** |
| **REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933** | **REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933** | **REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933** |
| **EHEALTH, INC.** | **EHEALTH, INC.** | **EHEALTH, INC.** |
| **(Exact name of Registrant as specified in its charter)** | **(Exact name of Registrant as specified in its charter)** | **(Exact name of Registrant as specified in its charter)** |
| **Delaware** | **13620 RANCH ROAD 620 N, SUITE A250**<br>**AUSTIN, TX 78717**  | **56-2357876** |
| **(State or other jurisdiction of**<br>**incorporation or organization)** | **(Address of principal executive offices, including zip code)** | **(I.R.S. Employer**<br>**Identification No.)** |
| **eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan**<br>**(Full title of the Plan)**  | **eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan**<br>**(Full title of the Plan)**  | **eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan**<br>**(Full title of the Plan)**  |
| **Gavin Galimi**<br>**Senior Vice President, General Counsel and Secretary**<br>**eHealth, Inc.** <br>**13620 Ranch Road 620 N, Suite A250**<br>**Austin, TX 78717**<br>**(737) 248-2340**  | **Gavin Galimi**<br>**Senior Vice President, General Counsel and Secretary**<br>**eHealth, Inc.** <br>**13620 Ranch Road 620 N, Suite A250**<br>**Austin, TX 78717**<br>**(737) 248-2340**  | **Gavin Galimi**<br>**Senior Vice President, General Counsel and Secretary**<br>**eHealth, Inc.** <br>**13620 Ranch Road 620 N, Suite A250**<br>**Austin, TX 78717**<br>**(737) 248-2340**  |
| **(Name, address, and telephone number, including area code, of agent for service)** | **(Name, address, and telephone number, including area code, of agent for service)** | **(Name, address, and telephone number, including area code, of agent for service)** |
|  | *Copies to:* |  |
|  | **Patrick J. Schultheis**<br>**Jeana S. Kim**<br>**Victor T. Nilsson**<br>**Wilson Sonsini Goodrich & Rosati**<br>**Professional Corporation**<br>**701 Fifth Avenue, Suite 5100**<br>**Seattle, WA 98104**<br>**(206) 883-2500** |  |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. | Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. | Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. |

---

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☐ | Accelerated filer | ☒ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☒ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act &nbsp;&nbsp;&nbsp;&nbsp;☐

------

**EXPLANATORY NOTE**

This Registration Statement on Form S-8 (the "Registration Statement") is filed by eHealth, Inc. (the "Registrant") for the purpose of registering 1,500,000 shares of the Registrant's common stock, par value $0.001 per share ("Common Stock"), reserved for issuance under the Registrant's Amended and Restated 2024 Equity Incentive Plan (the "Plan"), which was approved by the Registrant's stockholders at the Registrant's 2025 Annual Meeting of Stockholders on June 18, 2025. The additional shares are of the same class as other securities for which a registration statement relating to the Plan has previously been filed and is effective. Accordingly, pursuant to General Instruction E to Form S-8, this registration statement incorporates by reference the contents of the registration statement on Form S-8 filed by the Registrant with the Securities and Exchange Commission (the "Commission") on <u>[August 7, 2024](https://www.sec.gov/Archives/edgar/data/1333493/000133349324000127/s-8registrationstatementau.htm)</u> (File No. 333-281336) (the "Previous Form S-8"), including the information incorporated by reference therein and the periodic reports filed after the Previous Form S-8 to maintain current information about the Registrant.

------

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the Commission:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)The Registrant's Annual Report on <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/0001333493/000133349325000027/ehth-20241231.htm)</u> for the fiscal year ended December 31, 2024, filed with the Commission on February 27, 2025 (the "Annual Report");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)All other reports filed by the Registrant with the Commission pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), since the end of the fiscal year covered by the Annual Report; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)The description of the Registrant's Common Stock contained in the Registrant's Registration Statement on <u>[Form 8-A12B](https://www.sec.gov/Archives/edgar/data/1333493/000119312506204984/d8a12b.htm)</u> (File No. 001-33071) filed with the Commission on October 10, 2006, pursuant to Section 12(b) of the Exchange Act, including any amendments or reports filed for the purpose of updating such description.

All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

------

**Item 8. Exhibits.**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Exhibit Number** | **Description of Exhibit** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Incorporated by Reference** | **Filed Herewith** |
| **Exhibit Number** | **Description of Exhibit** | **Form** | **File No.** | **Exhibit** | **Filing Date** | **Filed Herewith** |
| 4.1 | <u>[Amended and Restated Certificate of Incorporation of the Registrant](https://www.sec.gov/Archives/edgar/data/1333493/000119312506087959/dex31.htm)</u> | S-1 | 333-133526 | 3.1 | April 25, 2006 |  |
| 4.2 | <u>[Certificate of Designations of Series A Preferred Stock, par value $0.001, of the Registrant](https://www.sec.gov/Archives/edgar/data/0001333493/000133349321000061/exhibit31certificateofdesi.htm)</u> | 8-K | 001-33071 | 3.1 | May 3, 2021 |  |
| 4.3 | <u>[Amended and Restated Bylaws of the Registrant](https://www.sec.gov/Archives/edgar/data/1333493/000133349322000156/ehealth-amendedandrestated.htm)</u> | 8-K | 001-33071 | 3.1 | December 19, 2022 |  |
| 4.4 | <u>[Form of the Registrant's Common Stock Certificate](https://www.sec.gov/Archives/edgar/data/1333493/000119312506138219/dex41.htm)</u> | S-1 | 333-133526 | 4.1 | June 28, 2006 |  |
| 5.1 | <u>[Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation](ex51opinions-82014equityin.htm)</u> |  |  |  |  | X |
| 23.1 | <u>[Consent of Independent Registered Public Accounting Firm](ex231consents-8aug2025.htm)</u> |  |  |  |  | X |
| 23.2 | <u>[Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (contained in Exhibit 5.1 hereto)](ex51opinions-82014equityin.htm)</u> |  |  |  |  | X |
| 24.1 | <u>[Power of Attorney (included on the signature page hereto)](#ic0aaec6164184708903f496972d4ddcc_7)</u> |  |  |  |  | X |
| 99.1 | <u>[Amended and Restated 2024 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1333493/000133349325000078/exhibit102amendedandrestat.htm)</u> | 8-K | 001-33071 | 10.2 | June 24, 2025 |  |
| 99.2 | <u>[Form of Notice of Stock Option Grant and Stock Option Agreement under the Amended and Restated 2024 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1333493/000133349324000127/ex992ehealth-formofstockop.htm)</u> | S-8 | 333-281336 | 99.2 | August 7, 2024 |  |
| 99.3 | <u>[Form of Notice of Time-Based Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the Amended and Restated 2024 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1333493/000133349324000127/ex993ehealth-formofrsuagre.htm)</u> | S-8 | 333-281336 | 99.3 | August 7, 2024 |  |
| 99.4 | <u>[Form of Notice of Performance-Based Restricted Stock Unit Grant and Restricted Stock Unit Agreement under the Amended and Restated 2024 Equity Incentive Plan](https://www.sec.gov/Archives/edgar/data/1333493/000133349324000127/ex994ehealth-formofprsuagr.htm)</u> | S-8 | 333-281336 | 99.4 | August 7, 2024 |  |
| 107 | <u>[Filing Fee Table](exfilingfees.htm)</u> |  |  |  |  | X |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Austin, State of Texas on August 7, 2025.

---

| | |
|:---|:---|
| **EHEALTH, INC.** | **EHEALTH, INC.** |
| By: | /s/ Francis Soistman |
|  | Francis Soistman |
|  | *Chief Executive Officer* |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints, jointly and severally, Francis Soistman and John Dolan, and each of them, as his or her true and lawful attorneys-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments to this registration statement, including post-effective amendments, and to file the same, with all exhibits thereto, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully for all intents and purposes as they, he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent or any of them, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Francis Soistman | <br>Chief Executive Officer and Director <br>(Principal Executive Officer) | August 7, 2025 |
| Francis Soistman | <br>Chief Executive Officer and Director <br>(Principal Executive Officer) |  |
| /s/ John Dolan | Senior Vice President, Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer) | August 7, 2025 |
| John Dolan | Senior Vice President, Chief Financial Officer<br>(Principal Financial Officer and Principal Accounting Officer) |  |

---

------

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Prama Bhatt | Director | August 7, 2025 |
| Prama Bhatt |  |  |
| /s/ Andrea C. Brimmer | Director | August 7, 2025 |
| Andrea C. Brimmer |  |  |
| /s/ Beth A. Brooke | Director | August 7, 2025 |
| Beth A. Brooke |  |  |
| /s/ A. John Hass, III | Director | August 7, 2025 |
| A. John Hass, III |  |  |
| /s/ Erin L. Russell | Director | August 7, 2025 |
| Erin L. Russell |  |  |
| /s/ Cesar M. Soriano | Director | August 7, 2025 |
| Cesar M. Soriano |  |  |
| /s/ Aaron C. Tolson | Director | August 7, 2025 |
| Aaron C. Tolson |  |  |
| /s/ Dale B. Wolf | Director | August 7, 2025 |
| Dale B. Wolf |  |  |

---

## Ex-Filing

?xml version='1.0' encoding='ASCII'? exfilingfees

**Exhibit 107**

**Calculation of Filing Fee Table**

**Form S-8**

(Form Type)

**eHealth, Inc.** (Exact Name of Registrant as Specified in its Charter)

<u>Table 1: Newly Registered Securities</u>

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;**Security Type** | **Security <br>Class <br>Title** | **Fee <br>Calculation <br>Rule** | &nbsp;&nbsp;&nbsp;&nbsp;**Amount Registered (1)** | **Proposed <br>Maximum <br>Offering <br>Price Per**<br>**Unit** | **Maximum <br>Aggregate <br>Offering <br>Price** | **Fee Rate** | **Amount <br>of <br>Registration Fee** |
| Equity | Common Stock, par value $0.001 per share (2) | Rule 457(c) and Rule 457(h) | 1500000 (2) | $3.295 (3) | $4942500 (3) | 0.00015310 | $756.70 |
| **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** | **Total Offering Amounts** |  | $4942500 |  | $756.70 |
| **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** | **Total Fee Offsets** |  |  |  | &nbsp;&nbsp;$0.00 |
| **Net Fee Due** | **Net Fee Due** | **Net Fee Due** | **Net Fee Due** |  |  |  | $756.70 |

---

(1) &nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement on Form S-8 (the "Registration Statement") shall also cover any additional shares of the registrant's common stock, par value $0.001 per share (the "Common Stock") that become issuable with respect to the securities identified in the above table under the registrant's Amended and Restated 2024 Equity Incentive Plan by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the registrant's receipt of consideration which results in an increase in the number of the registrant's outstanding shares of Common Stock.&nbsp;&nbsp;&nbsp;&nbsp;

(2)&nbsp;&nbsp;&nbsp;&nbsp;Consists of 1,500,000 shares of Common Stock reserved for issuance under the registrant's Amended and Restated 2024 Equity Incentive Plan.

(3)&nbsp;&nbsp;&nbsp;&nbsp;Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $3.295 per share, which is the average of the high and low prices per share of the registrant's Common Stock on the Nasdaq Global Market reported as of August 1, 2025.&nbsp;&nbsp;&nbsp;&nbsp;

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![image_0a.jpg](image_0a.jpg) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wilson Sonsini Goodrich & Rosati<br>Professional Corporation<br>701 Fifth Avenue<br>Suite 5100<br>Seattle, Washington 98104-7036<br>o: 206.883.2500 |

---

August 7, 2025

eHealth, Inc.

13620 Ranch Road 620 N, Suite A250

Austin, TX 78717

**Re:&nbsp;&nbsp;&nbsp;&nbsp;<u>Registration Statement on Form S-8</u>**

Ladies and Gentlemen:

At your request, we have examined the Registration Statement on Form S-8 (the "Registration Statement") to be filed by eHealth, Inc., a Delaware corporation (the "Company"), with the Securities and Exchange Commission (the "Commission"), on or about the date hereof, relating to the registration under the Securities Act of 1933, as amended (the "Act"), of 1,500,000 shares of common stock, par value $0.001 per share (the "Shares") to be issued under the Amended and Restated 2024 Equity Incentive Plan (the "Plan"). As your legal counsel, we have reviewed the actions proposed to be taken by you in connection with the issuance and sale of the Shares to be issued under the Plan.

On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when issued and sold in the manner described in the Plan and pursuant to the agreements that accompany the Plan, will be legally and validly issued, fully paid and nonassessable.

We hereby consent to the filing of this opinion as an exhibit to the above-referenced Registration Statement and to the use of our name wherever it appears in the Registration Statement and in any amendments thereto. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

Very truly yours,

WILSON SONSINI GOODRICH & ROSATI,

Professional Corporation&nbsp;&nbsp;&nbsp;&nbsp;

/s/ Wilson Sonsini Goodrich & Rosati, P.C.

AUSTIN BOSTON BOULDER BRUSSELS HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO

SALT LAKE CITY SAN DIEGO SAN FRANCISCO SEATTLE SHANGHAI WASHINGTON, DC WILMINGTON, DE

## Exhibit 23.1

**Exhibit 23.1**

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Amended and Restated 2024 Equity Incentive Plan of eHealth, Inc. of our reports dated February 27, 2025, with respect to the consolidated financial statements of eHealth, Inc. and the effectiveness of internal control over financial reporting of eHealth, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2024, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

San Francisco, California

August 7, 2025

<br>